NCT07619469

Brief Summary

Background: Motion sickness (MS) is a common syndrome characterized by autonomic and behavioral symptoms, such as nausea and dizziness, resulting from exposure to motion stimuli. Its pathophysiology is closely linked to sensory conflict and postural instability theories. While previous studies suggest that postural control, proprioception, and reaction times are affected in individuals susceptible to MS, there is a lack of comprehensive, comparative research evaluating all these parameters concurrently within the same cohort using standardized methods. Objective: This study aims to systematically measure balance, proprioceptive sensitivity, coordination, and reaction time parameters, and quantitatively analyze their relationship with motion sickness severity. Methodology: In this prospective, cross-sectional study, at least 41 participants aged 18-40 with motion sickness will be recruited. Participants will undergo motion sickness susceptibility and severity grading using the Motion Sickness Susceptibility Questionnaire Short Form (MSSQ-SF) and the Graybiel Scale. Objective assessments will include static and dynamic balance testing (ProKin®), knee joint position sense (Clinometer app), manual dexterity and dynamic balance coordination (Nine-Hole Peg Test, Tandem Walk, Romberg Test), and upper/lower extremity reaction time measurements (BlazePod system).

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for all trials

Timeline
0mo left

Started Jun 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Jun 2026Aug 2026

First Submitted

Initial submission to the registry

May 26, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

June 1, 2026

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 2, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 2, 2026

Expected
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 5, 2026

Last Updated

June 26, 2026

Status Verified

June 1, 2026

Enrollment Period

2 months

First QC Date

May 26, 2026

Last Update Submit

June 23, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Motion Sickness Severity (Graybiel Score)

    Used to grade the clinical severity of acute motion sickness symptoms (including nausea, cold sweating, increased salivation, and dizziness) following a randomized chair-rotation provocation protocol. 0 (Minimum) to 50 points (Maximum). Higher scores indicate greater symptom severity, representing a worse clinical outcome (scores of 16 or above designate frank sickness).

    1 hour

  • Static Balance

    Evaluated objectively using the ProKin® computerized balance system. Participants stand on the platform under conditions: double-leg with eyes open.

    1 hour

  • Dynamic Balance Performance

    Evaluated using the ProKin® system.

    1 hour

Secondary Outcomes (4)

  • Knee Joint Proprioception

    1 hour

  • Nine-Hole Peg Test (9HPT) Completion Time

    1 hour

  • Tandem Walk Test Error Count

    1 hour

  • Visual Reaction Time

    1 hour

Interventions

Participants will undergo a standardized battery of sensorimotor assessments, including static/dynamic balance tracking, knee joint position sense testing, manual dexterity/coordination tasks, and upper/lower extremity reaction time measurements, alongside a controlled motion sickness provocation session using a randomized chair-rotation protocol."

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of adult individuals aged between 18 and 40 years who exhibit susceptibility to motion sickness.

You may qualify if:

  • Individuals aged between 18 and 40 years.
  • Diagnosed with motion sickness according to the Motion Sickness -Susceptibility Questionnaire Short Form (MSSQ-SF).
  • Normal hearing acuity.
  • No history of acute or chronic vestibular disease, other than motion sickness.
  • Normal or corrected-to-normal vision.
  • Adequate physical capability to fully perform the measurement protocols, including balance, proprioception, coordination, and reaction time tests.

You may not qualify if:

  • Presence of any physical or orthopedic problem that could interfere with testing.
  • History of acute or chronic instability, unsteadiness, or vertigo.
  • Severe visual impairment.
  • History of prior ear surgery.
  • Presence of any neurological condition or disorder.
  • History of migraines.
  • Current use of medications that could affect balance or vestibular function (e.g., vestibular suppressants, sedatives).
  • Use of alcohol or psychoactive substances within the last 48 hours prior to testing.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Motion SicknessSomatosensory DisordersDizziness

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsSensation DisordersNeurologic ManifestationsNervous System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Assistant Professor

Study Record Dates

First Submitted

May 26, 2026

First Posted

June 2, 2026

Study Start

June 1, 2026

Primary Completion (Estimated)

August 2, 2026

Study Completion (Estimated)

August 5, 2026

Last Updated

June 26, 2026

Record last verified: 2026-06